| Table 4. Comparison of embryo transfer outcomes and pregnancy results between the DGC and Microfluidics (MC) groups Values are presented as number of cases (percentage). No significant differences were observed between groups in overall pregnancy rates, clinical pregnancy, ongoing pregnancy, or live birth rates. | |||
| Outcome | DGC group (n=49) | MC group (n=54) | p-value |
|---|---|---|---|
| Day-5 embryo transfer pregnancy rate | 29/35 (82.9%) | 27/32 (84.4%) | 0.867 |
| Day-4 embryo transfer pregnancy rate | 1/2 (50.0%) | 7/10 (70.0%) | 1.000 |
| Cleavage-stage embryo transfer pregnancy rate | 7/12 (58.3%) | 5/12 (41.67%) | 0.414 |
| Pregnancy rate (total) | 75.5% (37/49) | 72.2% (39/54) | 0.704 |
| Clinical pregnancy rate (total) | 67.4% (33/49) | 64.8% (35/54) | 0.786 |
| Ongoing pregnancy rate (total) | 63.3% (31/49) | 59.3% (32/54) | 0.676 |
| Live birth rate (total) | 63.3% (31/49) | 59.3% (32/54) | 0.676 |